Hepatit B virusu enfeksiyonunda delta antikoru (Anti-HDV) sıklığı ve klinik önemi

dc.contributor.author	Aykaç, İrfan
dc.date.accessioned	2021-05-08T08:23:36Z
dc.date.available	2021-05-08T08:23:36Z
dc.date.submitted	1995
dc.date.issued	2018-08-06
dc.identifier.uri	https://acikbilim.yok.gov.tr/handle/20.500.12812/649952
dc.description.abstract
dc.description.abstract		en_US
dc.language	Turkish
dc.language.iso	tr
dc.rights	info:eu-repo/semantics/embargoedAccess
dc.rights	Attribution 4.0 United States	tr_TR
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/
dc.subject	Endokrinoloji ve Metabolizma Hastalıkları	tr_TR
dc.subject	Endocrinology and Metabolic Diseases	en_US
dc.title	Hepatit B virusu enfeksiyonunda delta antikoru (Anti-HDV) sıklığı ve klinik önemi
dc.type	doctoralThesis
dc.date.updated	2018-08-06
dc.contributor.department	Diğer
dc.subject.ytm	Hepatitis D virus
dc.subject.ytm	Hepatitis B virus
dc.subject.ytm	Hepatitis D
dc.subject.ytm	Antibodies
dc.identifier.yokid	44723
dc.publisher.institute	Cerrahpaşa Tıp Fakültesi
dc.publisher.university	İSTANBUL ÜNİVERSİTESİ
dc.type.sub	medicineThesis
dc.identifier.thesisid	44723
dc.description.pages	29
dc.publisher.discipline	Diğer

Except where otherwise noted, this item's license is described as info:eu-repo/semantics/embargoedAccess